Herpes simplex genitalis antiviral treatment of first episode genital herpes: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 15: Line 15:
:*Saline bathing
:*Saline bathing
:*[[Analgesia]]
:*[[Analgesia]]
:*Topical anaesthetic agents such as [[Lidocaine|5% lidocaine]] ointment may be useful to apply especially prior to [[micturition]] but should be used with caution because of the risk of potential sensitization.
:*Topical anaesthetic agents such as [[Lidocaine|5% lidocaine]] ointment may be applied prior to [[micturition]] (risk of potential sensitization)
====Antimicrobial Therapy====
====Antimicrobial Therapy====
*1. '''Mild/Moderate genital HSV infection'''<ref>{{Cite journal| issn = 1545–8601| volume = 59| issue = RR–12| pages = 1–110| last1 = Workowski| first1 = Kimberly A.| last2 = Berman| first2 = Stuart| last3 = Centers for Disease Control and Prevention (CDC)| title = Sexually transmitted diseases treatment guidelines, 2010| journal = MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control| date = 2010–12–17| pmid = 21160459}}</ref>
*1. '''Mild/Moderate genital HSV infection'''<ref>{{Cite journal| issn = 1545–8601| volume = 59| issue = RR–12| pages = 1–110| last1 = Workowski| first1 = Kimberly A.| last2 = Berman| first2 = Stuart| last3 = Centers for Disease Control and Prevention (CDC)| title = Sexually transmitted diseases treatment guidelines, 2010| journal = MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control| date = 2010–12–17| pmid = 21160459}}</ref>

Revision as of 20:17, 1 October 2015

Sexually transmitted diseases Main Page

Herpes simplex Microchapters

Home

Patient Information

Genital Herpes
Congenital Herpes

Overview

Classification

Orofacial Infection
Anogenital Infection
Ocular Infection
Herpes Encephalitis
Neonatal Herpes
Herpetic Whitlow
Herpes Gladiatorum
Mollaret's Meningitis

Pathophysiology

Epidemiology and Demographics

Asymptomatic Shedding

Recurrences and Triggers

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Direct detection of Genital Lesions

Treatment

Antiviral Therapy

Overview
Antivirals for First Episode of Genital Herpes
Antivirals for Recurrent Genital Herpes

Primary Prevention

Counseling

Herpes simplex genitalis antiviral treatment of first episode genital herpes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Herpes simplex genitalis antiviral treatment of first episode genital herpes

CDC on Herpes simplex genitalis antiviral treatment of first episode genital herpes

Herpes simplex genitalis antiviral treatment of first episode genital herpes in the news

Blogs on Herpes simplex genitalis antiviral treatment of first episode genital herpes

Directions to Hospitals Treating Herpes simplex

Risk calculators and risk factors for Herpes simplex genitalis antiviral treatment of first episode genital herpes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Lakshmi Gopalakrishnan, M.B.B.S.

Overview

Newly acquired genital herpes can cause a prolonged clinical illness with severe genital ulcerations and neurologic involvement. Patients with first-episode herpes who have mild clinical manifestations initially can develop severe or prolonged symptoms. Therefore, all patients with first episodes of genital herpes should receive antiviral therapy.

Medical Therapy

  • All patients with a first-episode genital herpes require antimicrobial therapy.
  • Antiviral chemotherapy offers clinical benefits to the majority of symptomatic patients and is the mainstay of management.
  • Systemic antiviral drugs can partially control the signs and symptoms of herpes episodes when used to treat first clinical episodes and recurrent episodes or when used as daily suppressive therapy. However, these drugs neither eradicate latent virus nor affect the risk, frequency, or severity of recurrences after the drug is discontinued.
  • Topical therapy with antiviral drugs offers minimal clinical benefit, and its use is discouraged.

First Clinical Episode of Genital Herpes

Symptomatic Management

  • Many patients with first-episode herpes have mild clinical manifestations but later develop severe or prolonged symptoms. Therefore, patients with initial genital herpes should receive antiviral therapy.
  • General advice:

Antimicrobial Therapy

  • 1. Mild/Moderate genital HSV infection[1]
  • 1.1. First episode of genital herpes
  • Note (1): Treatment can be extended if healing is incomplete after 10 days of therapy
  • Note (2): Dose-adjustment is often necessary among patients with impaired renal function
  • 2. Severe genital HSV infection
  • 2.1. First episode of genital herpes
  • Preferred regimen: Acyclovir 5-10 mg/kg IV q8h for 2-7 days or until clinical improvement THEN {(Acyclovir 400 mg PO tid for at least 10 days OR Acyclovir 200 mg PO five times a day for at least 10 days OR Famciclovir 250 mg PO tid for at least 10 days OR Valacyclovir 1 g PO bid for at least 10 days)
  • Note: Dose-adjustment is often necessary among patients with impaired renal function

Management of Complications

  • Hospitalisation may be required for urinary retention, meningism, and severe constitutional symptoms.
  • If catheterisation is required, suprapubic catheterisation is preferred to prevent theoretical risk of ascending infection, to reduce the pain associated with the procedure, to allow normal micturition to be restored without multiple removals and re-catheterisations

References

  1. Workowski, Kimberly A.; Berman, Stuart; Centers for Disease Control and Prevention (CDC) (2010–12–17). "Sexually transmitted diseases treatment guidelines, 2010". MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 59 (RR–12): 1–110. ISSN 1545-8601. PMID 21160459. Check date values in: |date= (help)

Template:WH Template:WS